Transcode Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
6 LIBERTY SQUARE, BOSTON, MA, 02109
Mailing Address
6 LIBERTY SQUARE, BOSTON, MA, 02109
Phone
857-301-6857
Fiscal Year End
1231
EIN
811065054
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 15, 2026 | View on SEC |
| 8-K Current report of material events | April 7, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 8-K Current report of material events | February 23, 2026 | View on SEC |
| 8-K Current report of material events | February 5, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 7, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 8-K/A Current report amendment | December 23, 2025 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 3 Initial insider ownership report | December 22, 2025 | View on SEC |
Annual Reports
10-K
April 15, 2026
- Advancing lead drug candidate TTX-MC138 through Phase 0/1 clinical trials for solid tumors.
- Strategic acquisition of ABCJ, LLC (Polynoma) expanded pipeline into immunotherapy with BRACO-19.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.